Kane Biotech Inc. (TSXV:KNE)
Canada · Delayed Price · Currency is CAD 0.0300
0.00 (0.00%)
Oct 7, 2026, 9:30 AM EST
Kane Biotech Market Cap
Kane Biotech has a market cap or net worth of CAD 6.15 million as of October 9, 2026. It is the 45,584th most valuable company in the world and the 1,852nd biggest in Canada. Its market cap has decreased by 18.31% in one year.
Market Cap
6.15M
Enterprise Value
7.26M
Revenue
38.72K
Global Rank
Country Rank
#1,852 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since May 20, 2003, Kane Biotech's market cap has increased from 1.03M to 6.15M, an increase of 498.24%. That is a compound annual growth rate of 7.95%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2026 | 5.13M | -29.43% |
| Dec 30, 2025 | 7.26M | -51.98% |
| Dec 31, 2024 | 15.13M | 43.41% |
| Dec 29, 2023 | 10.55M | -6.12% |
| Dec 30, 2022 | 11.23M | -36.87% |
| Dec 31, 2021 | 17.80M | 17.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Britannia Life Sciences | 10.70M |
| Rakovina Therapeutics | 10.26M |
| COSCIENS Biopharma | 9.86M |
| PreveCeutical Medical | 9.57M |
| Marvel Biosciences | 8.49M |
| Glow Lifetech | 7.70M |
| PharmaTher Holdings | 5.46M |
| MYND Life Sciences | 5.22M |